Supratentorial ependymoma, ZFTA fusion-positive: developmental context, fusion-driven transcriptional dependence, and therapeutic vulnerabilities
Cellular Oncology · 20.11.2026
DOI: 10.1007/s13402-026-01328-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 20.11.2026. Verfasst von Linbo Li und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nantong University Special Research Fund for Clinical Medicine, Nantong Municipal Health Commission Research Project, Qidong Municipal Science and Technology Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Nantong University Special Research Fund for Clinical Medicine
- Nantong Municipal Health Commission Research Project
- Qidong Municipal Science and Technology Program
Zitieren
APA
Li, L., Xia, Y., Guo, L., Zhao, Q., Liu, C., Li, T., Qin, H., Li, Y., & Zhang, H. (2026). Supratentorial ependymoma, ZFTA fusion-positive: developmental context, fusion-driven transcriptional dependence, and therapeutic vulnerabilities. Cellular Oncology. https://doi.org/10.1007/s13402-026-01328-w
Vancouver
Li L, Xia Y, Guo L, Zhao Q, Liu C, Li T, et al. Supratentorial ependymoma, ZFTA fusion-positive: developmental context, fusion-driven transcriptional dependence, and therapeutic vulnerabilities. Cellular Oncology. 2026. doi:10.1007/s13402-026-01328-w
BibTeX
@article{Li2026,
author = {Li, Linbo and Xia, Ying and Guo, Ling and Zhao, Qianqian and Liu, Cenxi and Li, Tianze and Qin, Haoqi and Li, Yong and Zhang, Hua},
title = {Supratentorial ependymoma, ZFTA fusion-positive: developmental context, fusion-driven transcriptional dependence, and therapeutic vulnerabilities},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-026-01328-w}
}
EUVIMED